Efficacy and Safety of Subcutaneous Golimumab in Methotrexate‐Naive Patients With Rheumatoid Arthritis: Five‐Year Results of a Randomized Clinical Trial

OBJECTIVE: To evaluate the safety and efficacy of golimumab through 5 years in adults with active rheumatoid arthritis (RA) who had not previously received methotrexate (MTX). METHODS: In the GO‐BEFORE study, 637 MTX‐naive adult patients with active RA were randomized (1:1:1:1) to placebo + MTX (gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, Paul, Fleischmann, Roy M., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric Jason B., Churchill, Melvin, Park, Won, Pons‐Estel, Bernardo, Han, Chenglong, Gathany, Timothy A., Xu, Stephen, Zhou, Yiying, Leu, Jocelyn H., Hsia, Elizabeth C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089605/
https://www.ncbi.nlm.nih.gov/pubmed/26474452
http://dx.doi.org/10.1002/acr.22759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089605/
https://www.ncbi.nlm.nih.gov/pubmed/26474452
http://dx.doi.org/10.1002/acr.22759

Ejemplares similares